Şizofreni Tedavisinde Bilişsel Davranışçı Terapi
Yıl: 2021 Cilt: 58 Sayı: 1 Sayfa Aralığı: 61 - 65 Metin Dili: Türkçe DOI: 10.29399/npa.27418 İndeks Tarihi: 30-12-2021
Şizofreni Tedavisinde Bilişsel Davranışçı Terapi
Öz: Şizofreni pozitif ve negatif psikotik belirtilerden oluşan, davranışlar, duygulanım ve bilişsel işlevlerin etkilendiği çoğul etkenli bir rahatsızlıktır. Antipsikotik ilaçlar şizofreni tedavisinde ilk tercih olarak kullanılmaktadır fakat ilaç tedavisine uyum düşüktür. Tedavi uyumu olsa dahi kalıntı belirtiler ve tedaviye direnç görülebilmektedir. Bu nedenlerle güncel şizofreni tedavi kılavuzları antipsikotik tedaviye ek olarak Bilişsel Davranışçı Terapi’yi (BDT) önermektedir. BDT’nin özellikle pozitif belirtilerde etkin olduğu bilinmektedir. Bu yazıda şizofreni tedavisinde BDT uygulamaları ve etkinliğinin gözden geçirilmesi amaçlanmıştır.
Anahtar Kelime: Cognitive Behavioral Therapy in Treatment of Schizophrenia
Öz: Schizophrenia is a heterogeneous disorder that affects behavioral, affective, and cognitive domains and consists of positive and negative psychotic symptoms. Antipsychotic therapy is the first-line treatment for schizophrenia. However, treatment adherence levels are low. Even if there is good treatment compliance, residual symptoms and treatment resistance can be seen. As a result, recent schizophrenia treatment guidelines suggest Cognitive Behavioral Therapy (CBT) as adjunctive to antipsychotic therapy. CBT is known effective, especially on positive symptoms. This paper aims to review CBT practices and their effectiveness in schizophrenia.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
- 1. Patel KR, Cherian J, Gohil K, Atkinson D. Schizophrenia: Overview and treatment options. P T 2014;39:638–645. https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC4159061/pdf/ptj3909638.pdf
- 2. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RSE, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209–1223.
- 3. Conley RR, Buchanan RW. Evaluation of treatment-resistant schizophrenia. Schizophr Bull 1997;23:663–674.
- 4. Möller H-J, Czobor P. Pharmacological treatment of negative symptoms in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2015;265:567–578.
- 5. Brockman R, Murrell E. What Are the Primary Goals of Cognitive Behavior Therapy for Psychosis? A Theoretical and Empirical Review. J Cogn Psychother 2015;29:45–67.
- 6. Zubin J, Spring B. Vulnerability –a new view of schizophrenia. J Abnorm Psychol 1977;86:103–126.
- 7. Bentall R. Deconstructing the concept of schizophrenia. J Ment Heal 1993;2:223–238.
- 8. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE. A cognitive model of the positive symptoms of psychosis. Psychol Med 2001;31:189– 195.
- 9. Nowak I, Sabariego C, Switaj P, Anczewska M. Disability and recovery in schizophrenia: a systematic review of cognitive behavioral therapy interventions. BMC Psychiatry [Internet] 2016;16:228.
- 10. Tavares S. Severe Mental Disorders from a Cognitive-Behavioural Perspective: A Comprehensive Review from Conceptualization to Intervention. Curr Psychiatry Rev 2017;13:1–8.
- 11. Callcott P, Standart S, Turkington D. Trauma within psychosis: Using a CBT model for PTSD in psychosis. Behav Cogn Psychother 2004;32:239–244.
- 12. Jauhar S, McKenna PJ, Radua J, Fung E, Salvador R, Laws KR. Cognitivebehavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry [Internet] 2014;204:20–29.
- 13. Wykes T, Steel C, Everitt B, Tarrier N. Cognitive Behavior Therapy for Schizophrenia: Effect Sizes, Clinical Models, and Methodological Rigor. Schizophr Bull [Internet] 2008;34:523–537.
- 14. Van der Gaag M, Valmaggia LR, Smit F. The effects of individually tailored formulation-based cognitive behavioural therapy in auditory hallucinations and delusions: A meta-analysis. Schizophr Res [Internet] 2014;156:30–37.
- 15. Polese D, Fornaro M, Palermo M, de Luca V, Bartolomeis A. TreatmentResistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25- Year Systematic Review and Exploratory Meta-Analysis. Front Psychiatry 2019;10:210.
- 16. Sitko K, Bewick BM, Owens D, Masterson C. Meta-analysis and Metaregression of Cognitive Behavioral Therapy for Psychosis (CBTp) Across Time: The Effectiveness of CBT has Improved for Delusions. Schizophr Bull Open [Internet] 2020;1.
- 17. Candida M, Campos C, Monteiro B, Rocha N, Paes F, Nardi A, Machado S. Cognitive-behavioral therapy for schizophrenia: an overview on efficacy, recent trends and neurobiological findings. Med Express 2016;3:M160501.
- 18. Turkington D, Kingdon D. Using a normalising rationale in the treatment of schizophrenic patients. In: Haddock G, Slade PD, editors. CognitiveBehavioral Interventions with Psychotic Disorders. London and New York: Routledge; 1996. p.103–108.
- 19. Waters F, Allen P, Aleman A, Fernyhough C, Woodward TS, Badcock JC, Barkus E, Johns L, Varese F, Menon M, Vercammen A, Larøi F. Auditory hallucinations in schizophrenia and nonschizophrenia populations: a review and integrated model of cognitive mechanisms. Schizophr Bull [Internet] 2012;38:683–693.
- 20. Baumeister D, Sedgwick O, Howes O, Peters E. Auditory verbal hallucinations and continuum models of psychosis: A systematic review of the healthy voice-hearer literature. Clin Psychol Rev [Internet] 2017;51:125–141.
- 21. Hill K, Varese F, Jackson M, Linden DEJ. The relationship between metacognitive beliefs, auditory hallucinations, and hallucination-related distress in clinical and non-clinical voice-hearers. Br J Clin Psychol 2012;51:434–447.
- 22. Andrew EM, Gray NS, Snowden RJ. The relationship between trauma and beliefs about hearing voices: a study of psychiatric and non-psychiatric voice hearers. Psychol Med 2008;38:1409–1417.
- 23. Taylor G, Murray C. A qualitative investigation into non-clinical voice hearing: what factors may protect against distress? Ment Health Relig Cult [Internet] 2012;15:373–388.
- 24. Mehl S, Werner D, Lincoln TM. Does Cognitive Behavior Therapy for psychosis (CBTp) show a sustainable effect on delusions? A meta-analysis. Front Psychol [Internet] 2015;6:1450.
- 25. Ellett L, Lopes B, Chadwick P. Paranoia in a Nonclinical Population of College Students. J Nerv Ment Dis [Internet] 2003;191:425–430.
- 26. Ross CA, Joshi S. Paranormal experiences in the general population. J Nerv Ment Dis 1992;180:357–358.
- 27. Moritz S, Vitzthum F, Randjbar S, Veckenstedt R, Woodward TS. Detecting and defusing cognitive traps: metacognitive intervention in schizophrenia. Curr Opin Psychiatry 2010;23:561–569.
- 28. Yilmaz AE, Gencoz T, Wells A. Psychometric characteristics of the Penn State Worry Questionnaire and Metacognitions Questionnaire-30 and metacognitive predictors of worry and obsessive-compulsive symptoms in a Turkish sample. Clin Psychol Psychother 2008;15:424–439.
- 29. Sauvé G, Lavigne KM, Pochiet G, Brodeur MB, Lepage M. Efficacy of psychological interventions targeting cognitive biases in schizophrenia: A systematic review and meta-analysis. Clin Psychol Rev [Internet] 2020;78:101854.
- 30. Juárez-Ramos V, Montánchez Torres M. Cognitive Biases in Schizophrenia Spectrum Disorders. In: Shen YC, editor. Schizophrenia Treatment-The New Facets. Croatia: InTech; 2016. p.95–108.
- 31. Moritz S, Ramdani N, Klass H, Andreou C, Jungclaussen D, Eifler S, Englisch S, Schirmbeck F, Zink M. Overconfidence in incorrect perceptual judgments in patients with schizophrenia. Schizophr Res Cogn [Internet] 2014;1:165–170.
- 32. Beck A, Rector N. Cognitive Approaches to Schizophrenia: Theory and Therapy. Annu Rev Clin Psychol 2005;1:577–606.
- 33. Millan MJ, Fone K, Steckler T, Horan WP. Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment. Eur Neuropsychopharmacol 2014;24:645–692.
- 34. Batinic B. Cognitive Models of Positive and Negative Symptoms of Schizophrenia and Implications for Treatment. Psychiatr Danub 2019;31:181–184. http://www.psychiatria-danubina.com/UserDocsImages/ pdf/dnb_vol31_noSuppl%202/dnb_vol31_noSuppl%202_181.pdf
- 35. Grant PM, Beck AT. Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia. Schizophr Bull [Internet] 2009;35:798–806.
- 36. Sarin F, Wallin L. Cognitive model and cognitive behavior therapy for schizophrenia: an overview. Nord J Psychiatry 2014;68:145–153.
| APA | kart a, özdel k, Turkcapar M (2021). Şizofreni Tedavisinde Bilişsel Davranışçı Terapi. , 61 - 65. 10.29399/npa.27418 |
| Chicago | kart ayşegül,özdel kadir,Turkcapar Mehmet Hakan Şizofreni Tedavisinde Bilişsel Davranışçı Terapi. (2021): 61 - 65. 10.29399/npa.27418 |
| MLA | kart ayşegül,özdel kadir,Turkcapar Mehmet Hakan Şizofreni Tedavisinde Bilişsel Davranışçı Terapi. , 2021, ss.61 - 65. 10.29399/npa.27418 |
| AMA | kart a,özdel k,Turkcapar M Şizofreni Tedavisinde Bilişsel Davranışçı Terapi. . 2021; 61 - 65. 10.29399/npa.27418 |
| Vancouver | kart a,özdel k,Turkcapar M Şizofreni Tedavisinde Bilişsel Davranışçı Terapi. . 2021; 61 - 65. 10.29399/npa.27418 |
| IEEE | kart a,özdel k,Turkcapar M "Şizofreni Tedavisinde Bilişsel Davranışçı Terapi." , ss.61 - 65, 2021. 10.29399/npa.27418 |
| ISNAD | kart, ayşegül vd. "Şizofreni Tedavisinde Bilişsel Davranışçı Terapi". (2021), 61-65. https://doi.org/10.29399/npa.27418 |
| APA | kart a, özdel k, Turkcapar M (2021). Şizofreni Tedavisinde Bilişsel Davranışçı Terapi. Nöropsikiyatri Arşivi, 58(1), 61 - 65. 10.29399/npa.27418 |
| Chicago | kart ayşegül,özdel kadir,Turkcapar Mehmet Hakan Şizofreni Tedavisinde Bilişsel Davranışçı Terapi. Nöropsikiyatri Arşivi 58, no.1 (2021): 61 - 65. 10.29399/npa.27418 |
| MLA | kart ayşegül,özdel kadir,Turkcapar Mehmet Hakan Şizofreni Tedavisinde Bilişsel Davranışçı Terapi. Nöropsikiyatri Arşivi, vol.58, no.1, 2021, ss.61 - 65. 10.29399/npa.27418 |
| AMA | kart a,özdel k,Turkcapar M Şizofreni Tedavisinde Bilişsel Davranışçı Terapi. Nöropsikiyatri Arşivi. 2021; 58(1): 61 - 65. 10.29399/npa.27418 |
| Vancouver | kart a,özdel k,Turkcapar M Şizofreni Tedavisinde Bilişsel Davranışçı Terapi. Nöropsikiyatri Arşivi. 2021; 58(1): 61 - 65. 10.29399/npa.27418 |
| IEEE | kart a,özdel k,Turkcapar M "Şizofreni Tedavisinde Bilişsel Davranışçı Terapi." Nöropsikiyatri Arşivi, 58, ss.61 - 65, 2021. 10.29399/npa.27418 |
| ISNAD | kart, ayşegül vd. "Şizofreni Tedavisinde Bilişsel Davranışçı Terapi". Nöropsikiyatri Arşivi 58/1 (2021), 61-65. https://doi.org/10.29399/npa.27418 |
